(Q33702158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

CD26, let it cut or cut it down (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

S Korom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J Van Damme

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Scharpé

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

367-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

CD13--not just a marker in leukemia typing

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Proline-dependent structural and biological properties of peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Structure of proline iminopeptidase from Xanthomonas campestris pv. citri: a prototype for the prolyl oligopeptidase family.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Prolyl Oligopeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The purification, characterization and analysis of primary and secondary-structure of prolyl oligopeptidase from human lymphocytes. Evidence that the enzyme belongs to the alpha/beta hydrolase fold family.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The structure and function of CD26 in the T-cell immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

CD26 (dipeptidyl peptidase i.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

CD26 surface antigen expression on peripheral blood T lymphocytes from children with Down's syndrome (trisomy 21)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Structure−Activity Relationship of Diaryl Phosphonate Esters as Potent Irreversible Dipeptidyl Peptidase IV Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Involvement of dipeptidyl peptidase IV in an in vivo immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Potentiation of the immune response in HIV-1+ individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Metabolism of enterostatin in rat intestine, brain membranes, and serum: Differential involvement of proline-specific peptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Chemokine receptors and HIV-1: the fusion of two major research fields

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

1 reference

7 January 2021

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2899%2901486-3

7 January 2021

10.1016/S0167-5699(99)01486-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10431157%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference